You need to enable JavaScript to run this app.
Services
Solutions
About Us
Resources
Contact Us
Sign in
|
Register
EN
EN
CN
JP
Services
Solutions
About Us
Resources
Contact Us
Infographic
Rate Your CGT Readiness: Will regulatory or tech transfer challenges delay your path to market?
PDF - 72.9K
Download
Rate Your CGT Readiness
Five questions about regulatory strategy and technology transfer.
Rate Your CGT Readiness:
Will regulatory or tech
transfer challenges delay
your path to market?
Successfully bringing CGTs to market requires both a robust
regulatory strategy and the ability to achieve manufacturing
consistency across sites. But how do you know if your
program is ready?
Ask yourself the following questions to assess your readiness
for regulatory review and tech transfer — and to learn how to
get the support you need.
1. Have we built site-specific process
development into our times and budget?
Each site has specific technological limitations and
location-specific regulations to consider, which means
sponsors must be prepared to undergo site-specific
process development.
Tip: Scaling to new sites may also necessitate sourcing new
raw materials or suppliers before process redevelopment.
2. Which kinds of studies will we need to
file along with the findings from our
pivotal trials to demonstrate safety and
efficacy to regulators?
Sponsors must typically conduct more research to
support their filings than they would for chemical-based
therapeutics, such as small molecules.
3. Which CQAs will we need to measure —
and which orthogonal studies do we need to
complete — to maintain quality control?
Sponsors need to identify sources of variability, and
understand how they impact the end product, to achieve
consistent results across sites.
4. What does the onboarding process
look like for new sites, and how will we
deliver initial and ongoing training?
Onboarding should involve hands-on training,
including trial runs, as well as ongoing performance
assessment and education.
5. Which internal resources will we need to
support our regulatory and tech transfer
strategy, and where should we supplement
with outside support?
The ideal team should include cross-functional support,
including regulatory expertise in each relevant global
market, process development scientists, QC specialists
and experts in education/training.
You don’t need to build all of this in-house.
Get the cross-functional support you need to
accelerate your path to market
Often, sponsors need to look outside their organizations to find the
breadth and depth of cross-functional support they need to bring
innovative CGTs to market
Our track record
160+
IND clearances
150+
Protein and antibody
CMC/CMO projects
1,000+
GMP CGT batches
successfully delivered
ProBio CDMO can help, with deep expertise in developing challenging
molecules, including proteins, bispecific antibodies and CGTs.
LEARN MORE